Clinical TopicsNewsTechnologyWeb Exclusives

Metronidazole recall announced

Share

The U.S. Food and Drug Administration (FDA) announced that Teva Pharmaceuticals, USA is voluntarily recalling Metronidazole Tablets USP, 250mg, lot 312566, expiration date 05/2012 because “underweight” tablets may now have the full dose. Read more at http://www.fda.gov/Safety/Recalls/ucm239229.htm.

The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal. This has not been peer reviewed.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Test Your Knowledge

Which of the following statements accurately describes hypertrophic cardiomyopathy (HCM)?

More Perspectives